BridgeMD
New treatment option for Gout Chronic
Official title Drug-Drug Interaction Study of ABP-671 in Gout Patients
ClinicalTrials.gov ID: NCT07367971
What this study is testing
What is ABP-671 plus allopurinol?
ABP-671 plus allopurinol is an investigational medicine, being studied as a potential treatment for gout chronic.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This is a open-Label, Within-Subject Drug-Drug Interaction Study of ABP-671 Added to Stable Allopurinol Therapy in Gout Patients. Pharmacokinetic (PK) interaction between ABP-671 and Allopurinol will be evaluated in participants who are on stable Allopurinol therapy.
- Phase 1: an early, usually small safety study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75
You may be able to join if
- Adults 18-75 years with clinical diagnosis of gout.
- Stable Allopurinol therapy QD for ≥14 days prior to Day 1.
- Cohort N: Normal renal function.
- Cohort R: Moderate renal impairment.
You likely can't join if
- Clinically significant hepatic impairment.
- History of Allopurinol hypersensitivity.
- Pregnancy or breastfeeding.
The study team makes the final eligibility decision.
Where it's taking place
- Cary, North Carolina, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Cary, North Carolina, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.